Dar Al-Shifa Pharmaceuticals Past Earnings Performance
Past criteria checks 3/6
Dar Al-Shifa Pharmaceuticals has been growing earnings at an average annual rate of 86.9%, while the Pharmaceuticals industry saw earnings growing at 12.3% annually. Revenues have been growing at an average rate of 33.6% per year. Dar Al-Shifa Pharmaceuticals's return on equity is 17.9%, and it has net margins of 15.8%.
Key information
86.9%
Earnings growth rate
86.9%
EPS growth rate
| Pharmaceuticals Industry Growth | 12.4% |
| Revenue growth rate | 33.6% |
| Return on equity | 17.9% |
| Net Margin | 15.8% |
| Last Earnings Update | 31 Dec 2021 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How Dar Al-Shifa Pharmaceuticals makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 21 | 31 | 5 | 6 | 0 |
| 30 Sep 21 | 27 | 5 | 5 | 0 |
| 31 Dec 20 | 23 | 3 | 5 | 0 |
| 30 Jun 20 | 17 | 1 | 4 | 0 |
| 31 Mar 20 | 19 | 2 | 4 | 0 |
| 31 Dec 19 | 23 | -1 | 5 | 1 |
| 31 Dec 18 | 18 | 3 | 4 | 0 |
| 31 Dec 17 | 17 | 2 | 4 | 0 |
| 31 Dec 16 | 19 | 1 | 7 | 0 |
Quality Earnings: PHARMACARE has high quality earnings.
Growing Profit Margin: PHARMACARE's current net profit margins (15.8%) are higher than last year (11.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if PHARMACARE's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare PHARMACARE's past year earnings growth to its 5-year average.
Earnings vs Industry: PHARMACARE earnings growth over the past year (86.9%) exceeded the Pharmaceuticals industry 9.9%.
Return on Equity
High ROE: PHARMACARE's Return on Equity (17.9%) is considered low.